Inflammatory Myofibroblastic Tumor: Expanding the Spectrum of ALK Fusion Partners

被引：0
|
作者：
Swanson, David
Wong, Andrew
Charames, George
Tanguay, Jeffery J.
Kandel, Rita A.
Dickson, Brendan C.
机构：
[1] Mt Sinai Hosp, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[4] Peterborough Reg Hlth Ctr, Peterborough, ON, Canada
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
88
引用
收藏
页码：24A / 25A
页数：2
相关论文
共 50 条
  • [1] Inflammatory Myofibroblastic Tumor: Expanding the Spectrum of ALK Fusion Partners
    Swanson, David
    Wong, Andrew
    Charames, George
    Tanguay, Jeffery J.
    Kandel, Rita A.
    Dickson, Brendan C.
    MODERN PATHOLOGY, 2017, 30 : 24A - 25A
  • [2] CLTC-ALK fusion in inflammatory myofibroblastic tumor.
    Patel, AS
    Perlman, EJ
    Coffin, CM
    Griffin, CA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 73 - 73
  • [3] ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor
    Debiec-Rychter, M
    Marynen, P
    Hagemeijer, A
    Pauwels, P
    GENES CHROMOSOMES & CANCER, 2003, 38 (02): : 187 - 190
  • [4] Expanding the Landscape of ALK Fusion Partners in NSCLC
    Barua, S.
    Pagan, C.
    Freeman, C.
    Mansukhani, M.
    Sireci, A.
    Hsiao, S.
    Fernandes, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1052 - 1052
  • [5] Fusion of Dynactin 1 (DCTN1) to ALK in Inflammatory Myofibroblastic Tumor
    Wang, X.
    Krishnan, C.
    Nguyen, E.
    Mayer, K. J.
    Oliveira, J. L.
    Yi, J. E.
    Yang, P.
    Yaszemski, M. J.
    Maran, A.
    Erickson-Johnson, M. R.
    Oliveira, A. M.
    LABORATORY INVESTIGATION, 2011, 91 : 22A - 23A
  • [6] Fusion of Dynactin 1 (DCTN1) to ALK in Inflammatory Myofibroblastic Tumor
    Wang, X.
    Krishnan, C.
    Nguyen, E.
    Mayer, K. J.
    Oliveira, J. L.
    Yi, J. E.
    Yang, P.
    Yaszemski, M. J.
    Maran, A.
    Erickson-Johnson, M. R.
    Oliveira, A. M.
    MODERN PATHOLOGY, 2011, 24 : 22A - 23A
  • [7] ALK fusion genes in the pathogenesis of a nonhematopoietic malignancy -: Inflammatory myofibroblastic tumor (IMT).
    Ma, Z
    Hill, A
    Collins, M
    Witte, DP
    Bridge, J
    Ladanyi, M
    Cook, JR
    Dehner, LP
    Coffin, C
    Morris, SW
    BLOOD, 2000, 96 (11) : 88A - 88A
  • [8] FN1: A Novel Fusion Partner of ALK in an Inflammatory Myofibroblastic Tumor
    Ouchi, Kazutaka
    Miyachi, Mitsuru
    Tsuma, Yusuke
    Tsuchiya, Kunihiko
    Iehara, Tomoko
    Konishi, Eiichi
    Yanagisawa, Akio
    Hosoi, Hajime
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 909 - 911
  • [9] Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor
    Cools, J
    Wlodarska, I
    Somers, R
    Mentens, N
    Pedeutour, F
    Maes, B
    De Wolf-Peeters, C
    Pauwels, P
    Hagemeijer, A
    Marynen, P
    GENES CHROMOSOMES & CANCER, 2002, 34 (04): : 354 - 362
  • [10] Inflammatory Myofibroblastic Tumor Driven by Novel NUMA1-ALK Fusion Responds to ALK Inhibition
    Rao, Nisha
    Iwenofu, Hans
    Tang, Bingfeng
    Woyach, Jennifer
    Liebner, David A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (02): : 115 - 121
12345